Reducing the Population Health Burden of Cardiovascular Disease

Authors

Joseph Ladapo, MD, PhD, Assistant Professor, Section on Value and Effectiveness, in the Department of Population Health at NYU Langone Medical Center

Document Type

Podcast

Presentation Date

9-10-2014

Comments

Joseph Ladapo, MD, PhD is Assistant Professor, Section on Value and Effectiveness, in the Department of Population Health at NYU Langone Medical Center. His primary research interest focuses on the assessment of the cost-effectiveness of radiological technologies for cardiovascular disease.

Dr. Ladapo’s Forum presentation will provide an overview of the population health burden of Cardiovascular Disease in the US, including the cost-effectiveness of diagnostic technologies, policy changes influenced by the Affordable Care Act, and implications for prevention.

Dr. Ladapo graduated from Wake Forest University and received his MD from Harvard Medical School. He was honored with the Daniel Ford Award for health services and outcomes research during his residency at Johns Hopkins University. Dr. Ladapo holds a PhD in Health Policy from the Harvard Graduate School of Arts and Sciences.

Abstract

Learning Objectives

1. Describe the public health burden of cardiovascular disease in the US and the role of cardiovascular diagnostic testing.

2. Explain the comparative cost and cost-effectiveness of diagnostic technologies vs. public health interventions for reducing cardiovascular disease morbidity and mortality.

3. Identify the policy implications of recent utilization growth in diagnostic technologies for coronary heart disease, and the drivers of that growth.

4. Discuss the population health implications of the ACA for cardiovascular disease prevention and testing.

Presentation: 52 minutes

Recommended Citation